finance.yahoo.com
·
Sep 15
Electra targets $342m IPO to fund hyperinflammatory syndrome drug’s pivotal trials
Discussion
0 comments
Want to join the discussion?
Log in
or
create an account.
No comments yet. Start the discussion.